AnalystBook Research · Company Intelligence

LifeStance Health Group, Inc.

LFSTNasdaq

Built from LifeStance Health Group, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score 1.71 grey zone — between safe and distressedWatch
  • Earnings-manipulation signal · Beneish M -2.99 no flag raisedOK
  • Earnings quality 100/100 accruals in line with cashOK

Where the revenue comes from

Fiscal 2025, as LifeStance Health Group, Inc. reports it. History and quarterly detail are in the app.

  • Total Patient Service Revenue$1.4B
  • Commercial$1.3B
  • Government$76.1M
  • Self Pay$56.2M
  • Nonpatient Service Revenue$10.6M

Leadership changes

From LifeStance Health Group, Inc.'s own filings, the day they're filed.

  • Sarah Personette · director · departureeff. 2025-08-20
  • William Miller · directors · departureeff. 2025-08-19
  • Pablo Pantaleoni · Chief Digital Officer · departureeff. 2025-07-01

Latest filings

  • 8-K · Company announcement2026-08-06
  • 10-Q · Quarterly report2026-08-06
  • 8-K · Company announcement2026-07-07
  • 8-K · Company announcement2026-06-04
  • 8-K · Company announcement2026-05-12
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about LifeStance Health Group, Inc., every answer cited to the official filings🔒
  • The Intelligence Brief — added when LifeStance Health Group, Inc.'s brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.